Recognizing the Hidden Presentation of Sleep Apnea in Perimenopausal and Menopausal Women
A woman in her mid-40s or 50s describes fatigue, poor sleep, mood changes, and morning headaches. The natural clinical instinct is to consider perimenopause, menopause, depression, or anxiety. That path often leads to antidepressants, hormone therapy, or reassurance, while the real cause goes unaddressed. Research shows that up to 75% of women with obstructive sleep apnea remain undiagnosed, their symptoms frequently misattributed to other conditions common at this stage of life.¹
Why the explanation is incomplete
The hormonal explanation isn’t wrong; it’s incomplete. As estrogen and progesterone decline during perimenopause and menopause, upper airway muscle tone weakens and ventilatory stability decreases, significantly raising OSA risk.²
Yet women rarely present the way men do. Rather than snoring, gasping, and witnessed apneas, women with OSA more often report insomnia, daytime fatigue, depression, anxiety, morning headaches, and poor concentration.¹ Up to 40% report none of the classic symptoms at all.¹ The result is a clinical picture that resembles a mood or hormonal concern far more than a breathing disorder, and standard screening tools, designed primarily around male symptom profiles, often miss it entirely.²
Asking these questions can give a clearer picture
When a female patient in this age group presents with sleep complaints or mood changes, a few targeted questions can sharpen the clinical picture:
Do you wake up feeling unrefreshed, even after a full night’s sleep?
Do you have morning headaches that resolve within an hour of waking?
Does your partner notice any snoring, gasping, or restless sleep, even occasionally?
Do you wake frequently during the night without a clear reason?
These questions look beneath the surface and help distinguish OSA from the conditions it so closely mimics.
Remember this key clinical distinction
Menopause-related sleep disruption is typically tied to hot flashes, night sweats, or hormonal fluctuation, and often improves with hormone therapy. OSA-related disruption is driven by repeated airway collapse; it persists regardless of hormonal treatment and typically requires its own evaluation and management.³ When sleep or mood symptoms don’t improve as expected with standard interventions, OSA deserves serious consideration before the treatment plan escalates.
Timing matters, but the next steps are simple
When the evidence points beyond menopause or mood, connecting a patient with the right specialist sooner rather than later matters. Untreated OSA in women is associated with increased risk of hypertension, cardiovascular disease, and cognitive decline, all of which compound over time while the root cause goes unaddressed.
Arima Health’s virtual-first specialty sleep care model offers a direct path forward. Your patients can be screened quickly and connected with a sleep specialist within days, without the delays that so often accompany traditional referrals.
For a patient who has spent months or years managing symptoms that never fully resolved, better sleep and better health may be closer than she thinks.
References
¹ Leclerc J, et al. Advances in the diagnosis and treatment of obstructive sleep apnea in women. Pulmonary Therapy. 2026. doi:10.1007/s41030-026-00350-5. https://link.springer.com/article/10.1007/s41030-026-00350-5
² Levi Dunietz G, et al. OSA in women: associations with reproductive aging and screening challenges. CHEST. 2026;169(3):803–812. doi:10.1016/j.chest.2025.08.001. https://pubmed.ncbi.nlm.nih.gov/40885537/
³ Sung V, et al. Obstructive sleep apnoea in women: what do we know and what don’t we know? Respirology. 2025. doi:10.1002/resp.70136. https://onlinelibrary.wiley.com/doi/10.1002/resp.70136
This article is for general education and isn't a substitute for a diagnosis or medical advice from a licensed clinician.
